[PDF] Top 20 Electromechanical Poly(L-lactic acid) PLLA platforms for regenerative medicine

... de PLLA estão já aprovados para implantação no corpo humano pela Food and Drug Administration ...de PLLA com diferentes cristalinidades e espessuras com o intuito de melhorar as propriedades dielétricas do ... See full document

... of PLLA as a biofunctional platform, PLLA, a synthetic semicrystalline polyester, combining adjustable biodegradability and physical properties, has been chosen for this study and to further explore its ... See full document

... the platforms were ...the PLLA nanofibers present an accentuated decrease on actin levels and acquire a rounder morphology with few or no visible stress fibers due to F-actin disruption (Figure 5a, b left ... See full document

... Lactic acid is a bulk chemical, which requires its production to be ...in lactic acid fermentation will affect productivity if large amount of carbon source such as glucose is used ... See full document

... The use of DA agonists and enzyme inhibitors has been used as alternative to the above mentioned (Dexter and Jenner, 2013; Rascol et al., 2003). In the case of the DA agonists (e.g. pramipexole and ropinirole), studies ... See full document

... Although the main objective of this work was accomplished, as we have an evolved strain capable of using mannitol efficiently, it is also clear that the data collect is not enough to determine if the changes in the ... See full document

... with process development in mind. We present a novel, autoclavable, and microfabricated scale-down device designed for regenerative medicine process development. The microfabricated device contains a ... See full document

... on poly(lactic acid) (PLA) and bacterial cellulose, and, for comparative purposes, vegetal cellulose fibers, both in their pristine form or after acetylation, is ... See full document

... Synthetic biodegradable PLA, PGA, and copolymers of these, have been manufactured for biomedical applications since the 1970s. Since then, FDA has approved its use for a variety of clinical applications, [3-7], e.g. for ... See full document

... 38. Soure, A. M., Fernandes-Platzgummer, A., Moreira, F., Lilaia, C., Liu, S.- H., Ku, C.-P., Huang, Y.-F., Milligan, W., Cabral, J. M. S. & Silva, C. L. Integrated culture platform based on a human platelet ... See full document

... 11. Petchwattana, N., & Covavisaruch, S. (2014). Mechanical and morphological properties of wood plastic biocomposites prepared from toughened Poly(lacticacid) and rubber wood sawdust (Hevea brasiliensis). ... See full document

... obtain L-PRF, following the protocol of Zumstein and coauthors [27], 5 mL of peripheral blood from the same donor, were collected in tubes containing clot activator and separator gel (Vacutainer®) and immediately ... See full document

... The tensile strengths results of the produced biocomposites are shown in Figure 1. It was observed that the unreinforced matrix (PLABM) with a tensile strength of 45MPa had a higher strength than the reinforced ... See full document

... Lactic acid is the end product of anaerobic glycolysis. It is responsible for the generation of two ATP molecules of which provide energy during anaerobic conditions. This reaction is catalyzed by the ... See full document

... oral medicine; cell collection, isolation and preservation; bone regenerative potential comparison between dental stem cells and bone marrow stem cells; and various factors affecting bone regeneration in ... See full document

... Aims: Cell survival and antagonistic activity against Listeria innocua, Listeria monocytogenes and Staphylococcus aureus were investigated after spray-drying three bacteriocin-producing strains of lactic ... See full document

... of lactic acid and, as previously introduced, it is the monomer in the ROP reaction leading to HMW ...of lactic acid, lactide exists in three different forms, L-lactide, D-lactide and ... See full document

... One of our aims in preparing DMAB-stabilized PLGA nanoparticles was to establish a nanoparticulate drug carrier system for future oral drug delivery. Therefore the application of a colloidal system in physiological media ... See full document

... incubated at 37 °C, 5% CO 2 under basal medium. After 1, 7, and 21 days of cell seeding, 50 μ L of MTT solution (5 mg/mL in DMEM) was added to each well followed by incubation at 37 °C for 3 h. For dissolution of ... See full document

... nanoconjugates. Poly(malic acid) (PMA) has been extensively investigated as a water-soluble, biodegradable, and biocompatible polymer with remarkable advantages in clinical ...malic acid after ... See full document